Suppr超能文献

表面活性蛋白A和D的免疫调节作用:对肺部疾病的影响

Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.

作者信息

Pastva Amy M, Wright Jo Rae, Williams Kristi L

机构信息

Department of Cell Biology, Box 3709, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Proc Am Thorac Soc. 2007 Jul;4(3):252-7. doi: 10.1513/pats.200701-018AW.

Abstract

Surfactant, a lipoprotein complex, was originally described for its essential role in reducing surface tension at the air-liquid interface of the lung; however, it is now recognized as being a critical component in lung immune host defense. Surfactant proteins (SP)-A and -D are pattern recognition molecules of the collectin family of C-type lectins. SP-A and SP-D are part of the innate immune system and regulate the functions of other innate immune cells, such as macrophages. They also modulate the adaptive immune response by interacting with antigen-presenting cells and T cells, thereby linking innate and adaptive immunity. Emerging studies suggest that SP-A and SP-D function to modulate the immunologic environment of the lung so as to protect the host and, at the same time, modulate an overzealous inflammatory response that could potentially damage the lung and impair gas exchange. Numerous polymorphisms of SPs have been identified that may potentially possess differential functional abilities and may act via different receptors to ultimately alter the susceptibility to or severity of lung diseases.

摘要

表面活性剂是一种脂蛋白复合物,最初因其在降低肺气液界面表面张力方面的重要作用而被描述;然而,现在它被认为是肺免疫宿主防御的关键组成部分。表面活性剂蛋白(SP)-A和-D是C型凝集素家族中collectin家族的模式识别分子。SP-A和SP-D是先天免疫系统的一部分,调节其他先天免疫细胞(如巨噬细胞)的功能。它们还通过与抗原呈递细胞和T细胞相互作用来调节适应性免疫反应,从而将先天免疫和适应性免疫联系起来。新出现的研究表明,SP-A和SP-D的功能是调节肺的免疫环境,以保护宿主,同时调节可能潜在损害肺并损害气体交换的过度炎症反应。已经鉴定出SP的许多多态性,这些多态性可能具有不同的功能能力,并可能通过不同的受体起作用,最终改变对肺部疾病的易感性或严重程度。

相似文献

1
Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.
Proc Am Thorac Soc. 2007 Jul;4(3):252-7. doi: 10.1513/pats.200701-018AW.
2
Surfactant protein A and surfactant protein D variation in pulmonary disease.
Immunobiology. 2007;212(4-5):381-416. doi: 10.1016/j.imbio.2007.01.003. Epub 2007 Feb 23.
4
Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation.
J Allergy Clin Immunol. 2008 Nov;122(5):861-79; quiz 880-1. doi: 10.1016/j.jaci.2008.10.014.
5
Surfactant proteins A and D in pulmonary diseases of preterm infants.
Expert Rev Anti Infect Ther. 2012 May;10(5):573-84. doi: 10.1586/eri.12.34.
6
The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity.
Mol Immunol. 2005 Feb;42(3):279-87. doi: 10.1016/j.molimm.2004.07.014.
7
In defense of the lung: surfactant protein A and surfactant protein D.
Curr Opin Pharmacol. 2006 Jun;6(3):277-83. doi: 10.1016/j.coph.2006.02.003. Epub 2006 Mar 30.
8
Surfactant proteins SP-A and SP-D: structure, function and receptors.
Mol Immunol. 2006 Mar;43(9):1293-315. doi: 10.1016/j.molimm.2005.08.004. Epub 2005 Oct 5.
9
Collections and ficolins: humoral lectins of the innate immune defense.
Annu Rev Immunol. 2003;21:547-78. doi: 10.1146/annurev.immunol.21.120601.140954. Epub 2001 Dec 19.
10
Surfactant collectins and innate immunity.
Neonatology. 2008;93(4):288-94. doi: 10.1159/000121454. Epub 2008 Jun 5.

引用本文的文献

1
Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.
Pathophysiology. 2025 Jun 6;32(2):26. doi: 10.3390/pathophysiology32020026.
2
Insights into interstitial lung disease pathogenesis.
Breathe (Sheff). 2025 May 13;21(2):240261. doi: 10.1183/20734735.0261-2024. eCollection 2025 Apr.
4
Targeted labeling and depletion of alveolar macrophages using VeDTR mouse technology.
iScience. 2025 Feb 9;28(3):111975. doi: 10.1016/j.isci.2025.111975. eCollection 2025 Mar 21.
5
Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity.
Front Immunol. 2024 Dec 17;15:1491175. doi: 10.3389/fimmu.2024.1491175. eCollection 2024.
6
Monocytes/Macrophages in Helminth Infections: Key Players in Host Defence, Inflammation, and Tissue Repair.
Results Probl Cell Differ. 2024;74:315-340. doi: 10.1007/978-3-031-65944-7_13.
7
The implication of dendritic cells in lung diseases: Immunological role of toll-like receptor 4.
Genes Dis. 2023 Jun 27;11(6):101007. doi: 10.1016/j.gendis.2023.04.036. eCollection 2024 Nov.
8
Therapeutic and prognostic effect of disulfidptosis-related genes in lung adenocarcinoma.
Heliyon. 2024 Jun 29;10(13):e33764. doi: 10.1016/j.heliyon.2024.e33764. eCollection 2024 Jul 15.
9
Blood lipid profiles as a prognostic biomarker in idiopathic pulmonary fibrosis.
Respir Res. 2024 Jul 18;25(1):285. doi: 10.1186/s12931-024-02905-z.
10
The expression of the surfactant proteins SP-A and SP-B during postnatal alveolarization of the rat lung.
PLoS One. 2024 Mar 14;19(3):e0297889. doi: 10.1371/journal.pone.0297889. eCollection 2024.

本文引用的文献

1
Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health.
Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1052-63. doi: 10.1152/ajplung.00249.2006. Epub 2006 Dec 22.
2
Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
Clin Infect Dis. 2006 Dec 1;43(11):1426-33. doi: 10.1086/508775. Epub 2006 Oct 31.
3
Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens.
Am J Respir Cell Mol Biol. 2007 Jan;36(1):94-102. doi: 10.1165/rcmb.2006-0195OC. Epub 2006 Aug 10.
7
TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes.
Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L747-56. doi: 10.1152/ajplung.00401.2005. Epub 2006 Apr 28.
8
Oxidative damage to surfactant protein D in pulmonary diseases.
Free Radic Res. 2006 Apr;40(4):419-25. doi: 10.1080/10715760600571248.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验